CSIR launches ayurvedic anti-diabetic drug
The Council for Scientific and Industrial Research (CSIR) on Monday launched BGR-34, an ayurvedic drug designed to cure Type 2 Diabetes mellitus. "The modern diabetes drugs are known for side-effects and toxicity while BGR-34 works by controlling blood sugar and limiting the harmful effects of other drugs," Senior Principal Scientist AKS Rawat said. The drug will be available for ₹5 per tablet.